Maven Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,900
Closed -$4.75M 430
2025
Q4
$4.75M Sell
59,900
-132,200
-69% -$10.4M 0.11% 187
2025
Q3
$14.5M Buy
192,100
+65,600
+52% +$4.5M 0.36% 65
2025
Q2
$8.73M Buy
126,500
+9,200
+8% +$603K 0.21% 116
2025
Q1
$7.95M Buy
117,300
+79,000
+206% +$4.73M 0.24% 87
2024
Q4
$1.72M Buy
38,300
+20,000
+109% +$1.12M 0.04% 317
2024
Q3
$1.15M Sell
18,300
-5,100
-22% -$298K 0.02% 466
2024
Q2
$1.38M Buy
+23,400
New +$1.46M 0.03% 458
2024
Q1
Sell
-17,500
Closed -$1.38M 501
2023
Q4
$1.38M Sell
17,500
-10,700
-38% -$762K 0.03% 395
2023
Q3
$1.97M Buy
28,200
+18,600
+194% +$1.32M 0.02% 404
2023
Q2
$664K Buy
9,600
+1,200
+14% +$85.4K 0.01% 551
2023
Q1
$624K Sell
8,400
-5,100
-38% -$428K 0.01% 593
2022
Q4
$1.26M Sell
13,500
-1,100
-8% -$106K 0.03% 370
2022
Q3
$1.39M Buy
14,600
+11,300
+342% +$1.12M 0.03% 418
2022
Q2
$306K Sell
3,300
-7,900
-71% -$771K 0.01% 746
2022
Q1
$1.13M Sell
11,200
-6,300
-36% -$662K 0.04% 305
2021
Q4
$1.8M Buy
17,500
+13,700
+361% +$1.27M 0.05% 216
2021
Q3
$322K Buy
+3,800
New +$318K 0.01% 810

Other funds holding CVS

Maven Securities's CVS Position: Q1 2025 in Review

Maven Securities sold out of CVS Health (CVS) in Q1 2025, closing a stake of 28,790 shares — an estimated $1.72M sold.

Maven Securities first reported a position in CVS in Q2 2021 and held it in 8 quarters. The position peaked at $2.48M in Q2 2024. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Maven Securities reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 28,790 CVS Health shares in Q1 2025, an estimated $1.72M.
  • Maven Securities first reported a position in CVS Health in Q2 2021 and held it in 8 quarters.
  • Maven Securities's CVS Health position peaked at $2.48M in Q2 2024.
  • 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.